Thursday, January 4, 2024

Paxlovid treatment does not reduce risk of long COVID, study finds

A team of researchers has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection. They also found a higher proportion of individuals than previously reported with rebound symptoms and test-positivity after taking Paxlovid.

from Latest Science News -- ScienceDaily https://ift.tt/nbRtSei
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

One shot to stop HIV: MIT's bold vaccine breakthrough

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response with just one ...